Radiotherapy enhances the host immune system’s ability to recognize and eliminate tumor cells by upregulating MHC class I molecule expression on tumor cell surfaces, increasing CD8+ and CD4+ T lymphocyte infiltration, and improving tumor cell antigen recognition (Jin et al., 2023; Zeng et al., 2019). The gene discussed is CD4; the disease is neoplasm.